Immediate Impact
1 from Science/Nature 42 standout
Citing Papers
Neuroinflammation in Neurodegenerative Disorders: Current Knowledge and Therapeutic Implications
2024 Standout
Guidance for use of neurofilament light chain as a cerebrospinal fluid and blood biomarker in multiple sclerosis management
2024 Standout
Works of Christopher LaGanke being referenced
Immune thrombocytopenia in alemtuzumab-treated MS patients: Incidence, detection, and management
2019
Safety/tolerability of the anti-semaphorin 4D antibody VX15/2503 in a randomized phase 1 trial
2017
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Christopher LaGanke | 188 | 70 | 18 | 78 | 28 | 280 | |
| D. Teitelbaum | 134 | 50 | 6 | 67 | 15 | 316 | |
| Ide Smets | 129 | 40 | 18 | 66 | 27 | 289 | |
| Carolina Rush | 243 | 83 | 10 | 75 | 17 | 302 | |
| Eleonora Virgilio | 188 | 32 | 4 | 118 | 30 | 321 | |
| Ryohei Ohtani | 220 | 31 | 16 | 133 | 27 | 326 | |
| Jennifer Massey | 161 | 87 | 10 | 63 | 23 | 267 | |
| U Pätzold | 127 | 48 | 39 | 122 | 35 | 287 | |
| Zhiyun Lian | 180 | 18 | 11 | 147 | 22 | 278 | |
| В. Д. Назаров | 111 | 31 | 19 | 58 | 40 | 230 | |
| Tianrong Yeo | 133 | 30 | 33 | 94 | 33 | 305 |
All Works
Loading papers...